Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
16 avr. 2024 08h00 HE
|
Certara
Certara Cloud is a unifying platform that integrates Certara's scientific software. Clients use a single ID to access and manage their licensed software.
Global Biosimulation Market to Surge, Predicted CAGR of 16.98% from 2024 to 2034, Driven by Pharmaceutical R&D and Technological Advancements
29 janv. 2024 10h53 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market" report has been added to ResearchAndMarkets.com's offering. The advent of cutting-edge biosimulation technologies is...
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
13 déc. 2023 16h30 HE
|
Certara
Combined Certara-Applied Biomath organization establishes the life sciences industry’s largest quantitative systems pharmacology center.
Biosimulation Market To Reach USD 12.7 Billion By 2032 Report By DataHorizzon Research
06 déc. 2023 06h40 HE
|
DataHorizzon Research
Fort Collins, Colorado, Dec. 06, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, The Biosimulation Market size was valued at USD 2.8 Billion in 2022 and is anticipated to reach USD 12.7...
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
21 nov. 2023 16h30 HE
|
Certara
Certara's Simcyp™ Biopharmaceutics software helps biopharmaceutic, formulation & CMC scientists formulate complex new and generic drugs faster and cheaper.
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
19 sept. 2023 08h15 HE
|
Certara
PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to...
[Latest report] Biosimulation Market is estimated to be US$ 8969.47 million by 2030 with a CAGR of 15.4% during the forecast period – By PMI
07 sept. 2023 14h30 HE
|
PMI
Covina, Sept. 07, 2023 (GLOBE NEWSWIRE) -- According to the latest research study, the demand of “Biosimulation Market accounted for US$ 2113.91 million in 2020 and is estimated to be US$ 8969.47...
Certara Simcyp™ Group Awarded Two New Grants from US FDA
29 août 2023 08h15 HE
|
Certara
PRINCETON, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced that the Simcyp group has been awarded two new grants from the U.S. Food...
Certara Reports Second Quarter 2023 Financial Results
09 août 2023 16h15 HE
|
Certara
PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2023. ...
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
13 juil. 2023 16h30 HE
|
Certara
PRINCETON, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of...